FDA Inspection 1306740 — Evoendo, Inc.
The FDA completed an inspection of Evoendo, Inc. on March 2, 2026 in Grayslake, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 2, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Grayslake, IL (United States)